Xiong Dan, Yang Zhi-Gang, Li Qing-Hua, Wu Zu-Chang, Lü Jun-Ting
Department of Hematology, Guangdong Medical College and Affiliated Hospital, Zhanjiang 524001, Guangdong Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Oct;18(5):1310-5.
The aim of this study was to establish an efficient method for expansion in vitro of natural killer (NK) cells highly purified from human peripheral blood. The CD3-CD56+CD16+ NK cells purified by the negative sorting method of MACS (magnetic microbeads activated cells sorting) were expanded with the different combinations of IL-2, SCF, IL-15 in SCGM (stem cell growth medium) supplemented with 10% human AB serum for 18 days. Cultures were fed with fresh medium and cytokines every 3 days. The sum of cells was counted for evaluating the efficiency of expansion. Then the purity of the CD3-CD56+CD16+ NK cells were determined by flow cytometry and the cytotoxicity to K562 targets was detected by CCK-8 assay in the end. Furthermore, the same way was used to explore the relationship between the efficiency of expansion, cytotoxicity to K562 targets of NK cells and the dose of IL-2. The results showed that after peripheral blood mononuclear cells (PBMNC) were purified by the negative sorting method of MACS, the purity of CD3-CD56+CD16+ NK cells increased from (12.70±2.66)% to (93.03±1.72)%. The CD3-CD56+CD16+ NK cells purified by MACS were expanded with the different combinations of IL-2, SCF, IL-15 in SCGM supplemented with 10% human AB serum for 18 days. The expanding multiple of IL-2/IL-15/SCF group was significantly higher than other groups (p<0.05). The purity of NK cells in the groups with cytokines was not significantly lower than that before expansion (p>0.05). The cytotoxicity of the groups with cytokines was significantly higher than that before expansion. Especially, the cytotoxicity (%) of NK cells in IL-2/IL-15 group and IL-2/IL-15/SCF group was more than 90%. The expanding multiples of low-dose group, medium-dose group and high-dose group were significantly higher than that of zero-dose group (p<0.05), but no significant difference was found between themselves (p>0.05). The cytotoxicity of the groups with IL-2 was significantly higher than that before expansion. Cytotoxicity to K562 cells in high-dose group was significantly higher than that in others (p<0.05); there was no significant difference between low-dose group and medium-dose group (p>0.05). It is concluded that cytokines in the 4 groups were efficient for expansion and the cytotoxicity of highly purified NK cells in vitro. IL-2/SCF/IL-15 combination is the most efficient one among different combinations, and enhanced significantly the cytotoxicity of NK cells against K562 targets. The efficiency of expansion and the cytotoxicity in vitro of NK cells are not related with the dose of IL-2, when IL-2<1,000 U/ml. It is indicated that IL-2 of high-dose (≥1,000 U/ml) may enhance the cytotoxicity of NK cells in vitro more efficiently.
本研究的目的是建立一种高效的体外扩增方法,用于扩增从人外周血中高度纯化的自然杀伤(NK)细胞。采用MACS(磁性微珠激活细胞分选)阴性分选法纯化的CD3-CD56+CD16+NK细胞,在添加10%人AB血清的SCGM(干细胞生长培养基)中,用IL-2、SCF、IL-15的不同组合进行扩增,培养18天。每3天更换新鲜培养基和细胞因子。计数细胞总数以评估扩增效率。最后通过流式细胞术测定CD3-CD56+CD16+NK细胞的纯度,并通过CCK-8法检测对K562靶细胞的细胞毒性。此外,采用相同方法探讨NK细胞扩增效率、对K562靶细胞的细胞毒性与IL-2剂量之间的关系。结果显示,经MACS阴性分选法纯化外周血单个核细胞(PBMNC)后,CD3-CD56+CD16+NK细胞纯度从(12.70±2.66)%提高到(93.03±1.72)%。用IL-2、SCF、IL-15的不同组合在添加10%人AB血清的SCGM中对经MACS纯化的CD3-CD56+CD16+NK细胞进行18天的扩增。IL-2/IL-15/SCF组的扩增倍数显著高于其他组(p<0.05)。添加细胞因子组的NK细胞纯度与扩增前相比无显著降低(p>0.05)。添加细胞因子组的细胞毒性显著高于扩增前。特别是,IL-2/IL-15组和IL-2/IL-15/SCF组NK细胞的细胞毒性(%)超过90%。低剂量组、中剂量组和高剂量组的扩增倍数显著高于零剂量组(p<0.05),但它们之间无显著差异(p>0.05)。添加IL-2组的细胞毒性显著高于扩增前。高剂量组对K562细胞的细胞毒性显著高于其他组(p<0.05);低剂量组和中剂量组之间无显著差异(p>0.05)。结论是4组细胞因子对高度纯化的NK细胞体外扩增及细胞毒性有效。IL-2/SCF/IL-15组合在不同组合中扩增效率最高,并显著增强了NK细胞对K562靶细胞的细胞毒性。当IL-2<1000 U/ml时,NK细胞的扩增效率和体外细胞毒性与IL-2剂量无关。表明高剂量(≥1000 U/ml)IL-2可能更有效地增强NK细胞的体外细胞毒性。